IDenta Corp Reports First Quarter 2019 Results With Increase of 31% in Sales
JERUSALEM, May 15, 2019
JERUSALEM, May 15, 2019 /PRNewswire/ -- IDenta Corp. (OTC: IDTA) is a worldwide leader in the development of field Drug & Explosive detection kits and unique forensic products. Today IDenta Corp published its first quarter financial statement for 2019. The report shows an increase of more than thirty percent in sales compared with the same period last year.
Amichai Glattstein, CEO of IDenta Corp, stated: "Our first quarter results represented strong performance, particularly in current products, reflecting significant foundational work throughout 2018 to position IDenta for sustainable, profitable growth. We look forward to continued growth and further launches of new and unique products that will affect the company's growth in the near and far future."
About IDenta Corp.
Since 2002, IDenta Corporation and its subsidiary IDenta Ltd has been recognized as a worldwide leader in the development of proprietary on-site Drug, Drug Precursor and Explosive detection kits. IDenta develops, manufactures and distributes revolutionary products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Safe Harbor Statement
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
Company Contact Information:
SOURCE Identa Corp
- DGAP-News: EVOTEC: CYPROTEX AWARDED NEW 5 YEAR AGREEMENT WITH THE US ENVIRONMENTAL PROTECTION AGENCY ('EPA')
- DGAP-News: Nordex SE: Nordex Group posts Brazil order for 90 MW
- BGHL (GBP): NAV(s)
- BGHL (EUR): NAV(s)
- DGAP-News: DEMIRE Deutsche Mittelstand Real Estate AG: Moody's confirms Ba2 rating for DEMIRE
- Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla®